poisar

Stocks · News reference

BrewDog Recognized at Scottish Beer Awards

Fiscal.ai

Tilray Brands-owned BrewDog received multiple awards at the 2026 Scottish Beer Awards for its craft beer portfolio.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. The Motley FoolDavid Jagielski, Cpa

    Why Didn't Tilray Brands Make a Bid for Aurora Cannabis?

    Tilray Brands has not made a bid for Aurora Cannabis despite being an acquisition-hungry company, as its strategic focus has shifted toward U.S. beverage acquisitions and craft brewing rather than expanding in the competitive Canadian cannabis market. The company recently announced consolidation efforts in Canada to focus on profitability, making a major acquisition of a Canadian producer like Aurora less attractive to its long-term strategy.

  2. Globenewswire IncNa

    10 Barrel Brewing, Widmer Brothers and Hop Valley Named Official Craft Beer Partners of the Portland Trail Blazers

    Tilray Brands' three Oregon craft beer subsidiaries—10 Barrel Brewing, Widmer Brothers Brewing, and Hop Valley Brewing—have been named Official Craft Beer Partners of the Portland Trail Blazers. 10 Barrel also becomes the team's first Official Canned Cocktail Partner. The partnership expands craft beverage offerings at Moda Center through new venues like Schonely's Oregon Beer Hall and extends to the Rip City Bar Network.

  3. The Motley FoolDavid Jagielski, Cpa

    Does Marijuana Rescheduling Really Help Tilray's Stock?

    The U.S. government's reclassification of medical cannabis from Schedule I to Schedule III primarily benefits U.S.-based cannabis operators through lower tax bills, not Canadian producer Tilray. While rescheduling may be a step toward legalization, it doesn't guarantee future reform and could take years to materialize. Investors should be cautious about overreacting to rescheduling news, as Tilray's stock has historically surged temporarily on cannabis reform announcements only to decline to new lows.

  4. The Motley FoolDavid Jagielski, Cpa

    Tilray Raises Its Guidance for the Year. Is the Stock Finally Headed on the Right Track?

    Tilray announced a consolidation of its Canadian operations expected to generate $10 million in annual cost savings, leading to slightly raised adjusted EBITDA guidance for fiscal 2027 ($70-75 million vs. previous $68-75 million). However, the company continues to burn cash and faces challenges in the competitive Canadian cannabis market with low margins. Analysts remain cautious, suggesting investors take a wait-and-see approach as the improvements are insufficient to make the stock a compelling buy.